Medtronic, Inc.

Twelve, Inc.

Medtronic Vascular, Inc.

Medtronics, Inc.

Alexander J Hill

Timothy R Ryan

Timothy G Laske

Jerald Lamont Redmond

James R Keogh

Carol Elsa Eberhardt

Jason L Quill

Cynthia T Clague

Ana Menk

Paul T Rothstein

Mark T Stewart

Joseph C Morrow

Janice Lynn Shay

Mark J Capps

Michael M Green

Thierry Mesana

David E Francischelli

James R Skarda

Georg Börtlein

Allen J Tower

Jack D Lemmon

Marian Patricia Lally

Stephen T Kuehn

Billie J Millwee

Eugene Grossi

Debra A Taitague

Aubrey Galloway

Hugo Vanermen

Rudiger Lange

Paraic Frisby

Scott Robertson

Katherine Miyashiro

Richard Francis

Niall F Duffy

Nasser Rafiee

Kevin M Mauch

Paul Anthony Iaizzo

Marc A Anderson

Michael Gloss

Morgan House

Steven J Fraasch

Grainne Teresa Carroll

Geoffrey Orth

Brian T Howard

Benjamin Wong

Matthew Fleming

Paul Devereux

Michael J Hobday

Cathleen A Bergin

Elliot J Howard

Lynn A Davenport

Karl Olney

Elizabeth A Schotzko

Trenton Jay Rehberger

Luke Lehmann

Stuart R MacDonald

Qin Zhang

John Vandanacker

Jeffrey Madden

Ciaran McGuinness

Steven V Ramberg

Brian T McHenry

Michael Green

Edward Sarnowski

Stuart R Macdonald

Morgan M House

Jerald L Redmond

Janice L Shay

Carol E Eberhardt

Marian Lally

Georg Bortlein

A compressible and expandable stent assembly for implantation in a body lumen such as a mitral valve, the stent assembly including at least one stent barrel that is shaped and sized so that it allows for normal operation of adjacent heart structures. One or more stent barrels can be included in the stent assembly, where one or more of the stent barrels can include a cylinder with a tapered edge.

Stented heart valve devices and methods for atrioventricular valve replacement

Systems and methods for modifying a heart valve annulus in a minimally invasive surgical procedure. A helical anchor is provided, having a memory set to a coiled shape or state. The helical anchor is further configured to self-revert from a substantially straight state to the coiled state. The helical anchor is loaded within a needle that constrains the helical anchor to the substantially straight state. The needle is delivered to the valve annulus and inserted into tissue of the annulus. The helical anchor is then deployed from the needle (e.g., the needle is retracted from over the helical anchor). Once deployed, the helical anchor self-transitions toward the coiled shape, cinching engaged tissue of the valve annulus.

Mitral valve annuloplasty systems and methods

The present technology is a prosthetic heart valve device, and related systems and methods, for treating a native valve of a human heart having a native annulus and native leaflets. One embodiment comprises a valve support, a prosthetic valve assembly within the valve support, and an anchoring member having an upstream portion and a downstream portion. The device further includes an extension member coupled to the fixation frame and extending radially outward therefrom. The extension member includes a plurality of wires, at least a portion of which include an inner core surrounded by an outer material. The wires include a plurality of recesses extending through at least a portion of the thickness of the outer material, and a therapeutic agent in the recesses for delivery to the anatomy when the prosthetic heart valve device is positioned at a native annulus.

Prosthetic heart valve devices and associated systems and methods

A transcatheter delivery device including a catheter and at least one stabilizer useful for transseptal procedures. The stabilizer includes a shaft connected to an anchor. The anchor has a delivery position in which the anchor is collapsed against the shaft and a deployed position in which the anchor expands to engage a pulmonary vein or atrial appendage to support the catheter within the septal wall as the catheter moves within a left atrium. Various disclosed delivery devices are also configured to ablate tissue proximate the anchor and/or can be disconnected from the delivery device after the procedure to occlude an atrial appendage. Methods of using the disclosed delivery devices and treating a heart are also disclosed.

Stabilization of a transseptal delivery device

Methods and systems for monitoring and modifying pulsed field ablation (PFA) energy delivery to prevent patient safety risks and/or delivery device failure. In particular, some embodiments provide methods and systems for detecting and preventing arcs and arc-induced plasma, and their causal events, during delivery of pulsed field ablation energy, as well as methods and systems for identifying conditions leading to potential delivery device failure and correcting charge imbalance or asymmetry.

Methods of recognizing and eliminating arcs and arc induced plasma during energy delivery in tissue

Devices, methods, and systems for closure device for a left atrial appendage and, in particular, to a closure device that includes an anchor element and a disc element that are each individually chosen based on the anatomy of the patient's left atrial appendage and assembled before implantation. In one embodiment, a medical device comprises: an anchor element, the anchor element including a first connection element; and a disc element, the disc element including a second connection element pivotably coupled to the first connection element, the anchor element being sized to be received and retained within a left atrial appendage and the disc element being sized to completely cover an opening of the left atrial appendage.

Modular left atrial appendage closure

Methods of transcatheter delivery of a prosthetic heart valve. A distal region of a guide member assembly is advanced into a heart of a patient. The distal region is docked to native anatomy of the heart. A delivery device, including a collapsed prosthetic heart valve, is advanced over the docked guide member assembly. The collapsed prosthetic heart valve is located at an implantation site. The prosthetic heart valve is deployed from the delivery device, and then the delivery device is removed from the patient. At least a portion of the guide member assembly is removed from the patient. In some embodiments, the docking structure is docked to one or more of native mitral valve leaflets, chordae in the left ventricle, or walls of the left ventricle as part of a transseptal mitral valve delivery procedure.

Prosthetic heart valve delivery systems and methods

Helical coil mitral valve annuloplasty systems and methods

A compressible and expandable stent assembly for implantation in a body lumen such as a mitral valve, the stent assembly including at least one stent barrel that is shaped and sized so that it allows for normal operation of adjacent heart structures. One or more stent barrels can be included in the stent assembly, where one or more of the stent barrels can include a cylinder with tapered edge.

A stented valve having at least one leaflet made of pericardium or other material having a relatively thin profile at the annulus. The leaflets are attached via chords to a stent frame, where the chords are positioned to mimic the native valve anatomy and functionality. In particular, the valves of one exemplary embodiment of the invention are sized to replace a mitral valve and therefore the chords are arranged to prevent prolapse of the leaflets into the atrium. The stented valve has a relatively short height at its annulus due to the positioning of the chords. In addition, the stented valve is capable of being crimped to a small enough size that it can be delivered to the implantation site via transcatheter delivery systems and methods.

Prosthetic heart valve devices and methods of valve replacement

A method for treating a human patient includes emitting ultrasound energy from an ultrasound transducer positioned remotely from target tissue of the patient. The ultrasound transducer is positioned at a desired location relative to the patient and target tissue using location and imaging techniques. The method further includes focusing the ultrasound energy such that one or more focal points are directed to the target tissue of the patient and ablating the target tissue at each focal point. The target tissue is ablated via the focused ultrasound energy without ablating non-target tissue through which the ultrasound energy passes between the ultrasound transducer and the one or more focal points.

Method for ablating target tissue of a patient

Annuloplasty device for implantation adjacent an annulus of a tricuspid valve, the annulus comprising anterior, posterior and septal aspects adjacent anterior, posterior and septal leaflets, respectively, of the tricuspid valve, the device comprising: a ring body comprising: an anterior portion, a posterior portion and a septal portion shaped to conform to, and for implantation adjacent, the anterior, posterior and septal aspects of the annulus, respectively; and first and second end portions that are more flexible than a remainder of the ring body to provide a gradual transition from the remainder of the ring body to tissue of the tricuspid valve annulus; wherein the ring body is curvilinear, with substantially no flat portions, and forming a shape. Related devices, kits and sizer devices.

Annuloplasty device for tricuspid valve repair

Growing community of inventors

Blaine, MN, United States of America

Alexander J Hill